inovio pharmaceuticals stock price Archives

Why Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics Stocks Took Off on Thursday

The number of COVID-19 cases is rising again, and the companies working on the vaccine will likely further benefit from a cash flow into them. Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics stocks are good examples of this advantage.

Inovio (INO) Stock Up 2% in Pre-Market, Jim Cramer Shares His Thoughts on It

Business News, Editor's Choice, Market News, News, Stocks

By Darya Rudz May 18, 2020

In the last three months, INO has pulled in more than 181% returns. For 2020, Inovio (INO) investors have seen 233.33% returns.

Inovio (INO) Pharmaceuticals Stock Fell 5% as Class Action Lawsuit Brews

Business News, Editor's Choice, Market News, News, Stocks

By Tolu Ajiboye May 6, 2020

Inovio Pharmaceuticals might see a plunge in its 2020 gains if a class action lawsuit proves the company deliberately misled the public. Yesterday, INO stock lost over 5% of its value.

Business News, Editor's Choice, Market News, News, Stocks

INO Stock Up 4% Now, Inovio to Recruit All Coronavirus Vaccine Volunteers by End of April

By Darya Rudz Apr 24, 2020

Thanks to the progress in the vaccine development, Inovio (INO) stock has given a boost to investor confidence. Since the end of 2019, Inovio shares are 264,55% up. In the last month alone, the rise is 65%.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Rose 9.5% Yesterday, Up 4% in Pre-market as Vaccine Space Gets on Fire

By Steve Muchoki Apr 21, 2020

As of the market closed on Monday, shares of Inovio Pharmaceuticals (INO) were up by 9.6%, while Moderna (MRNA) rose 10.3%. Novavax (NVAX) blasted higher by 24.7%, and VBI Vaccines (VBIV) posted a comparable 24.2% gain.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Down 4% on Monday, 1% Today, Can It Be Multimillionaire-maker Stock?

By Andy Watson Apr 14, 2020

Inovio Pharmaceuticals alongside Moderna are edging close to providing a vaccine for the novel coronavirus. However, Inovio (INO) stock is down these days.

Business News, Market News, News, Stocks, Wall Street

Inovio (INO) Stock Fell 42% on Tuesday after Its 30% Drop on Monday

By Teuta Franjkovic Mar 11, 2020

Citron Research warned investors that Ino stock would fall back to $2 and called for the Securities and Exchange Commission to investigate Inovio and suspend trading of its stock.

Editor's Choice, Market News, News, Stocks

Inovio (INO) Stock Crashes Over 30%, Citron Research Casts Doubt on Coronavirus Vaccine

By Tolu Ajiboye Mar 10, 2020

Inovio (INO) stock has now erased some of its YTD gains after Citron Research suggested the company was grandstanding. Citron’s analysts now put INO at $2.

Business News, Market News, News, Stocks

Inovio (INO) Stock Rises 7.72%, 1 Million Coronavirus Vaccine Doses Expected by Year End

By Tolu Ajiboye Mar 5, 2020

Inovio(INO) stock is enjoying the rally as it put on almost 8% weight days after it announced that it will be speeding up plans for its coronavirus (COVID-19) vaccine.